Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center.

about

Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center.

Item

http://www.wikidata.org/entity/Q47109328

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effectiveness of long-term tre ...... a specialized diabetes center.

@en

Effectiveness of long-term tre ...... a specialized diabetes center.

@nl

type

Item

label

Effectiveness of long-term tre ...... a specialized diabetes center.

@en

Effectiveness of long-term tre ...... a specialized diabetes center.

@nl

prefLabel

Effectiveness of long-term tre ...... a specialized diabetes center.

@en

Effectiveness of long-term tre ...... a specialized diabetes center.

@nl

P1476

Effectiveness of long-term tre ...... a specialized diabetes center

@en

P2093

Areeya Malidaeng

http://www.w3.org/2001/XMLSchema#string

Ekgaluck Wanothayaroj

http://www.w3.org/2001/XMLSchema#string

Nalin Yenseung

http://www.w3.org/2001/XMLSchema#string

Sirinate Krittiyawong

http://www.w3.org/2001/XMLSchema#string

Soontaree Nakasatien

http://www.w3.org/2001/XMLSchema#string

Thep Himathongkam

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action

Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.

Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials

Dietary pattern and metabolic syndrome in thai adults

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2years.

Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use.

P2888

s13098-017-0297-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13098-017-0297-Y

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Phawinpon Chotwanvirat

Yotsapon Thewjitcharoen

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1093085579

http://www.w3.org/2001/XMLSchema#string

P698

29213337

http://www.w3.org/2001/XMLSchema#string

P932

5709980

http://www.w3.org/2001/XMLSchema#string